Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation

Significance Understanding how to optimize lipid-loading onto CD1d molecules is important to better harness invariant natural killer T (iNKT) cells’ central role at the interface between innate and adaptive immunity. We report that the lipid transfer proteins saposins play an essential role in modulating human iNKT cell autoreactivity to antigen-presenting cells activated by inflammatory stimuli. Lipid-loading occurs in an endo-lysosomal compartment, where saposins work as “lipid editors,” capable of fine-tuning loading and unloading of CD1d molecules and increasing the off-rate of CD1d-bound lipids. Lipid transfer proteins, such as molecules of the saposin family, facilitate extraction of lipids from biological membranes for their loading onto CD1d molecules. Although it has been shown that prosaposin-deficient mice fail to positively select invariant natural killer T (iNKT) cells, it remains unclear whether saposins can facilitate loading of endogenous iNKT cell agonists in the periphery during inflammatory responses. In addition, it is unclear whether saposins, in addition to loading, also promote dissociation of lipids bound to CD1d molecules. To address these questions, we used a combination of cellular assays and demonstrated that saposins influence CD1d-restricted presentation to human iNKT cells not only of exogenous lipids but also of endogenous ligands, such as the self-glycosphingolipid β-glucopyranosylceramide, up-regulated by antigen-presenting cells following bacterial infection. Furthermore, we demonstrated that in human myeloid cells CD1d-loading of endogenous lipids after bacterial infection, but not at steady state, requires trafficking of CD1d molecules through an endo-lysosomal compartment. Finally, using BIAcore assays we demonstrated that lipid-loaded saposin B increases the off-rate of lipids bound to CD1d molecules, providing important insights into the mechanisms by which it acts as a “lipid editor,” capable of fine-tuning loading and unloading of CD1d molecules. These results have important implications in understanding how to optimize lipid-loading onto antigen-presenting cells, to better harness iNKT cells central role at the interface between innate and adaptive immunity.

[1]  Jelena S. Bezbradica,et al.  Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition , 2013, Proceedings of the National Academy of Sciences.

[2]  J. Hampe,et al.  Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity , 2012, Nature Medicine.

[3]  S. Sansano,et al.  Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus , 2012, Nature Immunology.

[4]  G. Besra,et al.  Amide Analogues of CD1d Agonists Modulate iNKT-Cell-Mediated Cytokine Production , 2012, ACS chemical biology.

[5]  Ying Sun,et al.  Saposins utilize two strategies for lipid transfer and CD1 antigen presentation , 2012, Proceedings of the National Academy of Sciences.

[6]  G. Besra,et al.  Invariant natural killer T cells recognize lipid self-antigen induced by microbial danger signals , 2011, Nature Immunology.

[7]  Luca Cardelli,et al.  A Peptide Filtering Relation Quantifies MHC Class I Peptide Optimization , 2011, PLoS Comput. Biol..

[8]  A. McMichael,et al.  Identification of Self-lipids Presented by CD1c and CD1d Proteins* , 2011, The Journal of Biological Chemistry.

[9]  H. de la Salle,et al.  Fine tuning by human CD1e of lipid-specific immune responses , 2011, Proceedings of the National Academy of Sciences.

[10]  G. Besra,et al.  Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection , 2011, The Journal of experimental medicine.

[11]  G. Besra,et al.  Synthesis and biological activity of α-glucosyl C24:0 and C20:2 ceramides , 2010, Bioorganic & Medicinal Chemistry Letters.

[12]  G. Besra,et al.  Regulation of CD1 Antigen-presenting Complex Stability* , 2010, The Journal of Biological Chemistry.

[13]  R. Dwek,et al.  Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d , 2010, Proceedings of the National Academy of Sciences.

[14]  E. Adams,et al.  Recognition of Lyso-Phospholipids by Human Natural Killer T Lymphocytes , 2009, PLoS biology.

[15]  K. Robson,et al.  In vitro binding of HFE to the cation-independent mannose-6 phosphate receptor. , 2009, Blood cells, molecules & diseases.

[16]  G. Besra,et al.  Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide , 2009, Bioorganic & medicinal chemistry letters.

[17]  P. Savage,et al.  Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen αGalCer , 2009, Proceedings of the National Academy of Sciences.

[18]  P. Cresswell,et al.  Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation , 2009, Immunity.

[19]  G. Besra,et al.  Synthesis of threitol ceramide and [14C]threitol ceramide, non-glycosidic analogues of the potent CD1d antigen α-galactosyl ceramide , 2009 .

[20]  Wilfried Bardet,et al.  Determination of Cellular Lipids Bound to Human CD1d Molecules , 2009, PloS one.

[21]  P. Cresswell,et al.  Natural Lipid Ligands Associated with Human CD1d Targeted to Different Subcellular Compartments 1 , 2009, The Journal of Immunology.

[22]  Thomas Kolter,et al.  Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation. , 2009, Biochimica et biophysica acta.

[23]  G. Besra,et al.  Cutting Edge: Nonglycosidic CD1d Lipid Ligands Activate Human and Murine Invariant NKT Cells1 , 2008, The Journal of Immunology.

[24]  G. Besra,et al.  Phage display‐derived recombinant antibodies with TCR‐like specificity against α‐galactosylceramide and its analogues in complex with human CD1d molecules , 2008, European journal of immunology.

[25]  Anneliese O. Speak,et al.  Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation , 2007, Proceedings of the National Academy of Sciences.

[26]  Michael B. Brenner,et al.  CD1 antigen presentation: how it works , 2007, Nature Reviews Immunology.

[27]  C. Yip,et al.  Molecular imaging of membrane interfaces reveals mode of β-glucosidase activation by saposin C , 2007, Proceedings of the National Academy of Sciences.

[28]  Anneliese O. Speak,et al.  Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. , 2007, Immunity.

[29]  Y. Hannun,et al.  Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide , 2007, Nature.

[30]  K. Sandhoff,et al.  Saposin B mobilizes lipids from cholesterol‐poor and bis(monoacylglycero)phosphate‐rich membranes at acidic pH , 2007, The FEBS journal.

[31]  G. Besra,et al.  Distinct Endosomal Trafficking Requirements for Presentation of Autoantigens and Exogenous Lipids by Human CD1d Molecules1 , 2007, The Journal of Immunology.

[32]  G. Besra,et al.  The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation , 2007, The Journal of experimental medicine.

[33]  P. Savage,et al.  The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells , 2007, The Journal of experimental medicine.

[34]  P. Cresswell,et al.  Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules , 2007, Proceedings of the National Academy of Sciences.

[35]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[36]  Ralf Klingenstein,et al.  Saposin A Mobilizes Lipids from Low Cholesterol and High Bis(monoacylglycerol)phosphate-containing Membranes , 2006, Journal of Biological Chemistry.

[37]  C. Yip,et al.  Direct visualization of saposin remodelling of lipid bilayers. , 2006, Journal of molecular biology.

[38]  Weixian Lu,et al.  A time- and cost-efficient system for high-level protein production in mammalian cells. , 2006, Acta crystallographica. Section D, Biological crystallography.

[39]  S. Sonnino,et al.  Saposin B binds and transfers phospholipids Published, JLR Papers in Press, February 6, 2006. , 2006, Journal of Lipid Research.

[40]  K. Sandhoff,et al.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. , 2005, Annual review of cell and developmental biology.

[41]  A. Kaser,et al.  Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells , 2005, The Journal of experimental medicine.

[42]  H. Riezman,et al.  The ins and outs of sphingolipid synthesis. , 2005, Trends in cell biology.

[43]  G. Besra,et al.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Xiaoyang Qi,et al.  Saposin C-LBPA interaction in late-endosomes/lysosomes. , 2005, Experimental cell research.

[45]  L. Kaer,et al.  NKT cells: what's in a name? , 2004, Nature Reviews Immunology.

[46]  H. S. Kim,et al.  The role of CD1d in the immune response against Listeria infection. , 2004, Cellular immunology.

[47]  P. Savage,et al.  Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins , 2004, Science.

[48]  P. Cresswell,et al.  Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells , 2004, Nature Immunology.

[49]  S. Kaufmann,et al.  Saposin C is required for lipid presentation by human CD1b , 2004, Nature Immunology.

[50]  Satoshi Yasuda,et al.  Molecular machinery for non-vesicular trafficking of ceramide , 2003, Nature.

[51]  L. Bry,et al.  Mechanism of CD1d-restricted natural killer T cell activation during microbial infection , 2003, Nature Immunology.

[52]  N. Nagarajan,et al.  The Adaptor Protein AP-3 Is Required for CD1d-Mediated Antigen Presentation of Glycosphingolipids and Development of Vα14i NKT Cells , 2003, The Journal of experimental medicine.

[53]  G. Besra,et al.  Lysosomal Localization of Murine CD1d Mediated by AP-3 Is Necessary for NK T Cell Development 1 , 2003, The Journal of Immunology.

[54]  G. Privé,et al.  Crystal structure of saposin B reveals a dimeric shell for lipid binding , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  V. Cerundolo,et al.  Vα24-JαQ-Independent, CD1d-Restricted Recognition of α-Galactosylceramide by Human CD4+ and CD8αβ+ T Lymphocytes1 , 2002, The Journal of Immunology.

[56]  P. Cresswell,et al.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules , 2002, The EMBO journal.

[57]  Marc Bonneville,et al.  Autoreactivity by design: innate B and T lymphocytes , 2001, Nature Reviews Immunology.

[58]  R. Mehr,et al.  CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. , 2001, Immunity.

[59]  A. Kulkarni,et al.  Glycolipid antigen processing for presentation by CD1d molecules. , 2001, Science.

[60]  S. Porcelli,et al.  Murine CD1d-restricted T cell recognition of cellular lipids. , 2000, Immunity.

[61]  M. Kronenberg,et al.  Binding and Antigen Presentation of Ceramide-Containing Glycolipids by Soluble Mouse and Human Cd1d Molecules , 1999, The Journal of experimental medicine.

[62]  A. Dautry‐Varsat,et al.  Distinct Subsets of CD1d-restricted T Cells Recognize Self-antigens Loaded in Different Cellular Compartments , 1999, The Journal of experimental medicine.

[63]  B. Martin,et al.  Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. , 1997, Archives of biochemistry and biophysics.

[64]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[65]  X. Qi,et al.  Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase. , 1994, The Journal of biological chemistry.

[66]  E. Ginns,et al.  Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). , 1993, Archives of biochemistry and biophysics.

[67]  Y. Kishimoto,et al.  Binding and transport of gangliosides by prosaposin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Y. Kishimoto,et al.  Saposins: structure, function, distribution, and molecular genetics. , 1992, Journal of lipid research.

[69]  Y. Kishimoto,et al.  Saposin proteins: structure, function, and role in human lysosomal storage disorders , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  F. Winau,et al.  The immunological functions of saposins. , 2010, Advances in immunology.

[71]  V. Cerundolo,et al.  Harnessing invariant NKT cells in vaccination strategies , 2009, Nature Reviews Immunology.

[72]  P. Savage,et al.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d , 2002, Nature Immunology.

[73]  V. Cerundolo,et al.  Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. , 2002, Journal of immunology.

[74]  J. Whitelegge,et al.  Comparative lipid binding study on the cerebroside sulfate activator (saposin B) , 2001, Journal of neuroscience research.

[75]  P. Cresswell,et al.  HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. , 1995, Cell.

[76]  F. Oliveri,et al.  Myeloma based expression system for production of large mammalian proteins. , 1991, Trends in biotechnology.